This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

The Medicines Company (MDCO)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 376.73M 519.45M 315.38M 126.36M
Receivables 101.59M 86.24M 74.93M 47.83M
Inventories 87.10M 76.36M 45.14M 25.34M
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 591.44M 756.38M 481.72M 324.62M
Property, Plant & Equipment, Gross 60.71M 34.41M 35.42M 35.67M
Accumulated Depreciation & Depletion 21.44M 18.31M 17.44M 15.01M
Property, Plant & Equipment, Net 39.27M 16.10M 17.98M 20.66M
Intangibles 836.27M 50.08M 87.33M 82.92M
Other Non-Current Assets 16.61M 88.34M 12.50M 6.05M
Total Non-Current Assets 1.15B 215.81M 210.92M 149.50M
Liabilities & Shareholder Equity
Total Assets 1.74B 972.18M 692.65M 474.12M
Accounts Payable 26.91M 25.38M 6.59M 8.59M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 174.25M 135.21M 154.64M 85.37M
Long Term Debt 236.09M 226.11M 0.00 0.00
Deferred Income Taxes 128.68M 0.00 0.00 0.00
Other Non-Current Liabilities 310.10M 24.64M 26.37M 31.16M
Minority Interest -252.00K -84.00K 0.00 0.00
Total Non-Current Liabilities 674.53M 250.67M 26.37M 31.16M
Total Liabilities 848.78M 385.88M 181.00M 116.53M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 892.50M 586.31M 511.64M 357.60M
Common Par 66.00K 56.00K 54.00K 53.00K
Additional Paid In Capital 991.98M 697.43M 623.80M 596.67M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -44.90M -60.41M -111.66M -239.54M
Treasury Stock -50.00M -50.00M 0.00 0.00
Other Equity Adjustments -4.65M -766.00K -548.00K 420.00K
Total Capitalization 1.13B 812.42M 511.64M 357.60M
Total Equity 892.50M 586.31M 511.64M 357.60M
Total Liabilities & Stock Equity 1.74B 972.18M 692.65M 474.12M
Total Common Shares Outstanding 64.40M 53.96M 54.31M 53.46M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 2.19M 2.19M 0.00 0.00
Basic Weighted Shares Outstanding 58.10M 53.54M 53.50M 52.84M
Diluted Weighted Shares Outstanding 62.65M 55.35M 54.41M 53.18M
Number of Employees 571 538 421 420
Number of Part-Time Employees 0 0 0 0
MDCO News

MDCO The Medicines Company

Analysts Ratings for MDCO

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 2 3
Moderate Buy 1 1 1 1
Hold 4 4 4 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET MDCO ANALYST REPORT

Brokerage Partners

MDCO Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs